Brain

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

Clinician views Cortechs.ai neuroimaging analytics Clinician views Cortechs.ai neuroimaging analytics November 19, 2025Amsterdam, the Netherlands – Royal Philips (NYSE: PHG,...

Beacon Biosignals Announces Multi-Year Expansion of Strategic Collaboration with Takeda to Advance Narcolepsy Diagnosis and Neurobiomarker Discovery

BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Beacon Biosignals, a leading neurotechnology company powering AI-driven neurodiagnostics and precision medicines for...

Linus Health Highlights AI-Enabled Solutions Advancing Early Alzheimer’s Detection and Clinical Trial Readiness at CTAD 2025

BOSTON, Nov. 18, 2025 /PRNewswire/ -- Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and...

Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity

Peer-reviewed case report published in The American Journal on Addictions highlights significant clinical improvement and sustained abstinence following Nexalin’s non-invasive...

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer

RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinity Tb-161 antitumor activity driven by...

Synergy CHC Corp. (NASDAQ: SNYR) Adds Five New Direct Store Delivery Partners, Expanding FOCUSfactor Functional Beverage Distribution to Ten States Nationwide

WESTBROOK, Maine, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer...

Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

NEWTON, Mass., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel...

SoundHealth Launches Spatial Sleep: The World’s First Clinically Proven, Personalized, Drug-Free Wearable for Better Sleep

Proprietary acoustic sleep harmonization technology delivers tailored sound and vibration patterns based on each user’s unique craniofacial anatomy.SAN FRANCISCO--(BUSINESS WIRE)--SoundHealth,...

SoundHealth Launches Spatial Sleep: The World’s First Clinically Proven, Personalized, Drug-Free Wearable for Better Sleep

Proprietary acoustic sleep harmonization technology delivers tailored sound and vibration patterns based on each user’s unique craniofacial anatomy.SAN FRANCISCO--(BUSINESS WIRE)--SoundHealth,...

NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute

ZURICH and NESS ZIONA, Israel, Nov. 17, 2025 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or "the Company"), a clinical-stage...

Compassion Center, the Las Vegas Community, and Loved Ones Honor the Life and Immeasurable Legacy of Julie “Nurse Juhlzie” Monteiro with Community Celebrations December 13-14, 2025

error: Content is protected !!